Lung cancer remains the most frequently diagnosed cancer globally, with 2.5 million new cases, representing 12.4% of all ...

There are many sub-types of NSCLC, but the three main ones are adenocarcinoma, squamous cell carcinoma and large cell ...

No filter, high-puff frequency, higher quantities of nicotine and tar in bidi The Tribune, now published from Chandigarh, ...

Early cancer detection often marks the difference between successful treatment and grave outcomes. Understanding warning ...

The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Air pollution, defined as the contamination of indoor and outdoor environments by gases, ozone, and particulate matter (PM), ...

HK) ("Akeso" or the "Company") is pleased to announce that two of its independently developed, globally pioneering bispecific antibody drugs—cadonilimab Injection (PD-1/CTLA-4 bispecific antibody) and ...

Thursday announced positive data from INSIGHT-003 Phase I trial, evaluating the addition of Eftilagimod alpha or ...

Bevacizumab biosimilars have the potential to expand access and reduce costs without compromising patient outcomes in ...